146 related articles for article (PubMed ID: 7543045)
1. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation.
Thrailkill KM; Quarles LD; Nagase H; Suzuki K; Serra DM; Fowlkes JL
Endocrinology; 1995 Aug; 136(8):3527-33. PubMed ID: 7543045
[TBL] [Abstract][Full Text] [Related]
2. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases.
Kanzaki S; Hilliker S; Baylink DJ; Mohan S
Endocrinology; 1994 Jan; 134(1):383-92. PubMed ID: 7506211
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1.
Hurley MM; Abreu C; Hakeda Y
J Bone Miner Res; 1995 Feb; 10(2):222-30. PubMed ID: 7538725
[TBL] [Abstract][Full Text] [Related]
4. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells.
Conover CA; Kiefer MC
J Clin Endocrinol Metab; 1993 May; 76(5):1153-9. PubMed ID: 7684391
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
Durham SK; Kiefer MC; Riggs BL; Conover CA
J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases.
Fowlkes JL; Suzuki K; Nagase H; Thrailkill KM
Endocrinology; 1994 Dec; 135(6):2810-3. PubMed ID: 7527335
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases.
Fowlkes JL; Thrailkill KM; Serra DM; Suzuki K; Nagase H
Prog Growth Factor Res; 1995; 6(2-4):255-63. PubMed ID: 8817668
[TBL] [Abstract][Full Text] [Related]
8. Alterations in insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis in transformed osteoblastic cells.
Durham SK; Riggs BL; Harris SA; Conover CA
Endocrinology; 1995 Apr; 136(4):1374-80. PubMed ID: 7534697
[TBL] [Abstract][Full Text] [Related]
9. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta.
Durham SK; Riggs BL; Conover CA
J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411
[TBL] [Abstract][Full Text] [Related]
10. IGFBP-4 degradation by pregnancy-associated plasma protein-A in MC3T3 osteoblasts.
Bunn RC; Green LD; Overgaard MT; Oxvig C; Fowlkes JL
Biochem Biophys Res Commun; 2004 Dec; 325(3):698-706. PubMed ID: 15541345
[TBL] [Abstract][Full Text] [Related]
11. Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum.
Kübler B; Cowell S; Zapf J; Braulke T
Endocrinology; 1998 Apr; 139(4):1556-63. PubMed ID: 9528934
[TBL] [Abstract][Full Text] [Related]
12. Development of specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -6): analysis of IGFBP production by rat granulosa cells.
Liu XJ; Malkowski M; Guo Y; Erickson GF; Shimasaki S; Ling N
Endocrinology; 1993 Mar; 132(3):1176-83. PubMed ID: 7679972
[TBL] [Abstract][Full Text] [Related]
13. Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts.
Nam TJ; Busby WH; Clemmons DR
Endocrinology; 1996 Dec; 137(12):5530-6. PubMed ID: 8940380
[TBL] [Abstract][Full Text] [Related]
14. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells.
Parker A; Gockerman A; Busby WH; Clemmons DR
Endocrinology; 1995 Jun; 136(6):2470-6. PubMed ID: 7538463
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction.
Salahifar H; Baxter RC; Martin JL
Endocrinology; 1997 Apr; 138(4):1683-90. PubMed ID: 9075731
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures.
Fowlkes JL; Enghild JJ; Suzuki K; Nagase H
J Biol Chem; 1994 Oct; 269(41):25742-6. PubMed ID: 7523391
[TBL] [Abstract][Full Text] [Related]
17. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.
Irwin JC; Dsupin BA; Giudice LC
J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic activity degrading insulin-like growth factor-binding protein-2, -3, -4, and -5 in healthy growing and atretic follicles in the pig ovary.
Besnard N; Pisselet C; Monniaux D; Monget P
Biol Reprod; 1997 Apr; 56(4):1050-8. PubMed ID: 9096890
[TBL] [Abstract][Full Text] [Related]
19. Stimulatory effect of a phorbol ester on expression of insulin-like growth factor (IGF) binding protein-2 and level of IGF-I receptors in mouse osteoblastic MC3T3-E1 cells.
Hakeda Y; Yoshizawa K; Hurley M; Kawaguchi H; Tezuka K; Tanaka K; Satoh T; Kumegawa M
J Cell Physiol; 1994 Mar; 158(3):444-50. PubMed ID: 7510294
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: independence from IGF receptor binding.
Myers SE; Cheung PT; Handwerger S; Chernausek SD
Endocrinology; 1993 Oct; 133(4):1525-31. PubMed ID: 7691578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
